Cohera Medical’s Novel Sealant Picked For FDA 'Expedited Access'
This article was originally published in The Gray Sheet
Executive Summary
FDA launched its new Expedited Access Pathway in April, and Cohera Medical is now the first company to announce participation for its Sylys Surgical Sealant. Under the program, Cohera hopes to use an interim trial analysis to accelerate the product's path to market.